Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice

Seokmann Hong, David C. Scherer, Nagendra Singh, Sanjeev K. Mendiratta, Isao Serizawa, Yasuhiko Koezuka, Luc Van Kaer

Research output: Contribution to journalReview article

104 Citations (Scopus)

Abstract

CD1 molecules represent a distinct lineage of antigen-presenting molecules that are evolutionarily related to the classical major histo-compatibility complex (MHC) class I and class II molecules. Unlike the classical MHC products that bind peptides, CD1 molecules have evolved to bind lipids and glycolipids. Murine and human CD1d molecules can present glycolipid antigens such as α-galactosylceramide (α-GalCer) to CD1d-restricted natural killer (NK) T cells. Using CD1d knockout mice we demonstrated that CD1d expression is required for the development of NK T cells. These animals were also deficient in the rapid production of interleukin-4 and interferon-γ in response to stimulation by anti-CD3 antibodies. Despite these defects, CD1d knockout animals were able to generate strong T-helper type 1 (T(H)1) and T(H)2 responses. Spleen cells from these animals neither proliferated nor produced cytokines in response to stimulation by α-GalCer. Repeated injection of α-GalCer into wild-type but not CD1d mutant mice was able to clear metastatic tumors. We further showed that α-GalCer can inhibit disease in diabetes-prone non-obese diabetic mice. Collectively these findings with CD1d knockout animals indicate a critical role for CD1d-dependent T cells in various disease conditions, and suggest that α-GalCer may be useful for therapeutic intervention in these diseases.

Original languageEnglish (US)
Pages (from-to)31-44
Number of pages14
JournalImmunological Reviews
Volume169
DOIs
StatePublished - Jul 29 1999
Externally publishedYes

Fingerprint

Antigen Presentation
Knockout Mice
Immune System
Lipids
Natural Killer T-Cells
Glycolipids
CD1d Antigen
Galactosylceramides
Antigens
Inbred NOD Mouse
Interleukin-4
Interferons
Anti-Idiotypic Antibodies
Spleen
Cytokines
T-Lymphocytes
Peptides
Injections
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Lipid antigen presentation in the immune system : Lessons learned from CD1d knockout mice. / Hong, Seokmann; Scherer, David C.; Singh, Nagendra; Mendiratta, Sanjeev K.; Serizawa, Isao; Koezuka, Yasuhiko; Van Kaer, Luc.

In: Immunological Reviews, Vol. 169, 29.07.1999, p. 31-44.

Research output: Contribution to journalReview article

Hong, Seokmann ; Scherer, David C. ; Singh, Nagendra ; Mendiratta, Sanjeev K. ; Serizawa, Isao ; Koezuka, Yasuhiko ; Van Kaer, Luc. / Lipid antigen presentation in the immune system : Lessons learned from CD1d knockout mice. In: Immunological Reviews. 1999 ; Vol. 169. pp. 31-44.
@article{937c00ee6d934a1198d75198f3f4783e,
title = "Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice",
abstract = "CD1 molecules represent a distinct lineage of antigen-presenting molecules that are evolutionarily related to the classical major histo-compatibility complex (MHC) class I and class II molecules. Unlike the classical MHC products that bind peptides, CD1 molecules have evolved to bind lipids and glycolipids. Murine and human CD1d molecules can present glycolipid antigens such as α-galactosylceramide (α-GalCer) to CD1d-restricted natural killer (NK) T cells. Using CD1d knockout mice we demonstrated that CD1d expression is required for the development of NK T cells. These animals were also deficient in the rapid production of interleukin-4 and interferon-γ in response to stimulation by anti-CD3 antibodies. Despite these defects, CD1d knockout animals were able to generate strong T-helper type 1 (T(H)1) and T(H)2 responses. Spleen cells from these animals neither proliferated nor produced cytokines in response to stimulation by α-GalCer. Repeated injection of α-GalCer into wild-type but not CD1d mutant mice was able to clear metastatic tumors. We further showed that α-GalCer can inhibit disease in diabetes-prone non-obese diabetic mice. Collectively these findings with CD1d knockout animals indicate a critical role for CD1d-dependent T cells in various disease conditions, and suggest that α-GalCer may be useful for therapeutic intervention in these diseases.",
author = "Seokmann Hong and Scherer, {David C.} and Nagendra Singh and Mendiratta, {Sanjeev K.} and Isao Serizawa and Yasuhiko Koezuka and {Van Kaer}, Luc",
year = "1999",
month = "7",
day = "29",
doi = "10.1111/j.1600-065X.1999.tb01304.x",
language = "English (US)",
volume = "169",
pages = "31--44",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Lipid antigen presentation in the immune system

T2 - Lessons learned from CD1d knockout mice

AU - Hong, Seokmann

AU - Scherer, David C.

AU - Singh, Nagendra

AU - Mendiratta, Sanjeev K.

AU - Serizawa, Isao

AU - Koezuka, Yasuhiko

AU - Van Kaer, Luc

PY - 1999/7/29

Y1 - 1999/7/29

N2 - CD1 molecules represent a distinct lineage of antigen-presenting molecules that are evolutionarily related to the classical major histo-compatibility complex (MHC) class I and class II molecules. Unlike the classical MHC products that bind peptides, CD1 molecules have evolved to bind lipids and glycolipids. Murine and human CD1d molecules can present glycolipid antigens such as α-galactosylceramide (α-GalCer) to CD1d-restricted natural killer (NK) T cells. Using CD1d knockout mice we demonstrated that CD1d expression is required for the development of NK T cells. These animals were also deficient in the rapid production of interleukin-4 and interferon-γ in response to stimulation by anti-CD3 antibodies. Despite these defects, CD1d knockout animals were able to generate strong T-helper type 1 (T(H)1) and T(H)2 responses. Spleen cells from these animals neither proliferated nor produced cytokines in response to stimulation by α-GalCer. Repeated injection of α-GalCer into wild-type but not CD1d mutant mice was able to clear metastatic tumors. We further showed that α-GalCer can inhibit disease in diabetes-prone non-obese diabetic mice. Collectively these findings with CD1d knockout animals indicate a critical role for CD1d-dependent T cells in various disease conditions, and suggest that α-GalCer may be useful for therapeutic intervention in these diseases.

AB - CD1 molecules represent a distinct lineage of antigen-presenting molecules that are evolutionarily related to the classical major histo-compatibility complex (MHC) class I and class II molecules. Unlike the classical MHC products that bind peptides, CD1 molecules have evolved to bind lipids and glycolipids. Murine and human CD1d molecules can present glycolipid antigens such as α-galactosylceramide (α-GalCer) to CD1d-restricted natural killer (NK) T cells. Using CD1d knockout mice we demonstrated that CD1d expression is required for the development of NK T cells. These animals were also deficient in the rapid production of interleukin-4 and interferon-γ in response to stimulation by anti-CD3 antibodies. Despite these defects, CD1d knockout animals were able to generate strong T-helper type 1 (T(H)1) and T(H)2 responses. Spleen cells from these animals neither proliferated nor produced cytokines in response to stimulation by α-GalCer. Repeated injection of α-GalCer into wild-type but not CD1d mutant mice was able to clear metastatic tumors. We further showed that α-GalCer can inhibit disease in diabetes-prone non-obese diabetic mice. Collectively these findings with CD1d knockout animals indicate a critical role for CD1d-dependent T cells in various disease conditions, and suggest that α-GalCer may be useful for therapeutic intervention in these diseases.

UR - http://www.scopus.com/inward/record.url?scp=0032775884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032775884&partnerID=8YFLogxK

U2 - 10.1111/j.1600-065X.1999.tb01304.x

DO - 10.1111/j.1600-065X.1999.tb01304.x

M3 - Review article

C2 - 10450506

AN - SCOPUS:0032775884

VL - 169

SP - 31

EP - 44

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

ER -